Gwenaël Labouèbe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gwenaël Labouèbe has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Alexandre Picard
Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
1 shared publication- Ali Hallaj
Department of Biomedical Sciences, University of Lausanne, 1005 Lausanne, Switzerland
1 shared publication Ana Rodriguez Sanchez‐Archidona
Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
1 shared publication- Bernard Thorens
Center for Integrative Genomics, University of Lausanne
1 shared publication - Christian Widmann
Department of Biomedical Sciences, University of Lausanne
1 shared publication - Evgeniya Trofimenko
Department of Biomedical Sciences, University of Lausanne
1 shared publication
Latest Publications
- Open Access
- 15 October 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 215, 107330
Monitoring endosomal escape of fluorescent cell-penetrating peptides
- 15 October 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 215, 107330
Open AccessMonitoring endosomal escape of fluorescent cell-penetrating peptides
- Open Access
- 14 June 2023
- Published by Springer Nature in EMBO Reports
- Vol. 24 (8) , e57344
Tmem117 in AVP neurons regulates the counterregulatory response to hypoglycemia
The counterregulatory response to hypoglycemia (CRR), which ensures a sufficient glucose supply to the brain, is an essential survival function. It is orchestrated by incompletely characterized glucose-sensing neurons, which trigger a coordinated autonomous and hormonal response that restores normoglycemia. Here, we investigate the role of hypothalamic Tmem117, identified in a genetic screen as a regulator of CRR. We show that Tmem117 is expressed in vasopressin magnocellular neurons of the hypothalamus. Tmem117 inactivation in these neurons increases hypoglycemia-induced vasopressin secretion leading to higher glucagon secretion in male mice, and this effect is estrus cycle phase dependent in female mice. Ex vivo electrophysiological analysis, in situ hybridization, and in vivo calcium imaging reveal that Tmem117 inactivation does not affect the glucose-sensing properties of vasopressin neurons but increases ER stress, ROS production, and intracellular calcium levels accompanied by increased vasopressin production and secretion. Thus, Tmem117 in vasopressin neurons is a physiological regulator of glucagon secretion, which highlights the role of these neurons in the coordinated response to hypoglycemia.
- 14 June 2023
- Published by Springer Nature in EMBO Reports
- Vol. 24 (8) , e57344
Open AccessTmem117 in AVP neurons regulates the counterregulatory response to hypoglycemia
The counterregulatory response to hypoglycemia (CRR), which ensures a sufficient glucose supply to the brain, is an essential survival function. It is orchestrated by incompletely characterized glucose-sensing neurons, which trigger a coordinated autonomous and hormonal response that restores normoglycemia. Here, we investigate the role of hypothalamic Tmem117, identified in a genetic screen as a regulator of CRR. We show that Tmem117 is expressed in vasopressin magnocellular neurons of the hypothalamus. Tmem117 inactivation in these neurons increases hypoglycemia-induced vasopressin secretion leading to higher glucagon secretion in male mice, and this effect is estrus cycle phase dependent in female mice. Ex vivo electrophysiological analysis, in situ hybridization, and in vivo calcium imaging reveal that Tmem117 inactivation does not affect the glucose-sensing properties of vasopressin neurons but increases ER stress, ROS production, and intracellular calcium levels accompanied by increased vasopressin production and secretion. Thus, Tmem117 in vasopressin neurons is a physiological regulator of glucagon secretion, which highlights the role of these neurons in the coordinated response to hypoglycemia.